Trial
NCT01744171
Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Roswell Park Cancer Institute
Collaborators
—
Condition
Recurrent Melanoma
Intervention
Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
Why stopped
Study was Suspended since 2018; PI decided to terminate.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-22